Eisai’s Leqembi breakthrough unveiled in Q2 fiscal report
USA — Eisai has unveiled a remarkable surge in Leqembi, its revolutionary Alzheimer’s...
Read More
Tag: Alzheimer’s disease
Aga Khan University’s BMI partner with global Alzheimer’s collective to address research gaps in dementia in Africa
KENYA — The Aga Khan University’s Brain & Mind Institute (AKU-BMI) and the Davos Alzheimer’s...
Read More
FDA grants full approval to Leqembi, a groundbreaking drug slowing disease progression
USA —The U.S. Food and Drug Administration (FDA) has granted traditional full approval to Leqembi,...
Read More
Lilly’s Alzheimer’s drug shows promising results with 35% reduction in disease progression
USA — Eli Lilly’s experimental Alzheimer’s drug, donanemab, has shown promising...
Read More
Eisai’s sales projections for Leqembi exceed US$7 billion by 2030
JAPAN —Eisai has announced that its Alzheimer’s disease drug Leqembi (lecanemab), developed...
Read More
New blood test can detect Alzheimer’s disease 3.5 years before diagnosis—Study
UNITED KINGDOM — Scientists have developed a blood-based test that could be used to predict the...
Read More
Early Alzheimer’s disease detection sensor in development
USA — Simon Fraser University (SFU) Nanodevice Fabrication Group researchers are working on a new...
Read More
Sildenafil emerges as candidate drug for Alzheimer’s Disease—Study
USA — A 2021 Cleveland Clinic-led study identified sildenafil, an FDA-approved therapy for...
Read More
Eisai’s Alzheimer’s treatment scores US FDA approval, to retail at US$26,500 per year
USA — The U.S. Food and Drug Administration (FDA) has approved a drug that may help people in the...
Read More
Experimental drug appears to slow progression of Alzheimer’s disease, but safety concerns loom
USA—An experimental drug that removes a substance called amyloid from the brain appears to slow...
Read More
Biogen withdraws application for Alzheimer’s drug in Europe
EUROPE – Biogen has withdrawn its application for the Alzheimer’s disease drug in the...
Read More
Fujifilm develops artificial intelligence tech for predicting Alzheimer’s progression
JAPAN – Fujifilm Corporation has developed artificial intelligence technology that can predict...
Read More
LATEST DIGITAL MAGAZINE
